Rocket


Overview
Financials
News + Filings
Key Docs
Insiders

 
 

CHINA BIOPHARMA, INC. (CBPC) Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-08Dec-31-07Dec-31-06Dec-31-05
Revenues5.50.71.20.4
            Revenue growth704.6%-42.7%216.1% 
Cost of goods sold5.30.61.10.2
Gross profit0.20.10.10.2
            Gross margin3.8%10.7%10.6%53.5%
Selling, general and administrative0.71.43.82.2
EBIT-1.0-1.3-3.7-2.7
            EBIT margin-17.4%-195.8%-304.6%-718.4%
Pre-tax income-0.9-1.8-4.7-2.8
Income taxes0.0-0.10.00.0
            Tax rate 6.0%0.0%0.0%
Net income-0.9-1.7-4.7-2.8
            Net margin-16.8%-240.0%-392.9%-746.7%
 
Diluted EPS($0.22)($1.48)($0.06)($0.03)
Shares outstanding (diluted)4.21.185.581.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy